Cancer BiologybioRxivPreprint
Inhibition of RNA Polymerase I Transcription Activates Targeted DNA Damage Response and Enhances the Efficacy of PARP Inhibitors in High-Grade Serous Ovarian Cancer
Elaine Sanij, Katherine M. Hannan, Shunfei Yan…·Richard B Pearson
This study shows CX-5461, an RNA polymerase I inhibitor, enhances PARP inhibitor efficacy in HR-deficient HGSOC by inducing replication stress and DNA damage, overcoming resistance mechanisms.
DOI 10.1101/621623